C

Amgen Inc. AMGN.TO

TSX
Recommendation
Dividend Power Score
Day's Range
$34.45$35.46
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
My Lists My Alerts
Access our Premium Ratings
Get Access

AMGN.TO Rating

Reward
Risk

AMGN.TO Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

AMGN.TO Company Overview

Amgen Inc. is a U.S.-based biotechnology company focused on the discovery, development, manufacturing, and commercialization of human therapeutics. The company operates primarily within the biotechnology and biopharmaceutical industries, with products spanning oncology, inflammation, bone health, cardiovascular disease, nephrology, and rare diseases. Amgen’s revenue is driven largely by biologic medicines, biosimilars, and specialty therapeutics marketed to hospitals, specialty pharmacies, healthcare providers, and government health systems. Major commercial products include therapies such as Enbrel, Prolia, XGEVA, Otezla, Repatha, and TEPEZZA, along with a growing biosimilars portfolio.

Founded in 1980 as Applied Molecular Genetics, Amgen was among the earliest biotechnology firms to successfully commercialize recombinant DNA-based medicines. The company expanded significantly through internal research and strategic acquisitions, evolving from an early biotechnology pioneer into one of the world’s largest independent biopharmaceutical companies. Amgen’s strategic positioning has historically centered on biologics manufacturing expertise, strong intellectual property capabilities, large-scale commercial infrastructure, and long product life cycles supported by advanced biologic development platforms.

Data compiled by narrative technology. May contain errors.
Sector

AMGN.TO Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

AMGN.TO Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

AMGN.TO Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

AMGN.TO Price History

Loading...
Beta
--
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
--
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--

AMGN.TO Valuation

Market Cap
Market Cap Rank
#88
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

AMGN.TO Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
Dividend Per Share (TTM)

AMGN.TO Corporate Info

Phone Number
805 447 1000
Address
One Amgen Center Drive
Thousand Oaks, CA 91320-1799
Country
Year Founded

AMGN.TO Filings

Filing Date
Wednesday, November 4, 2026
Period Date
Wednesday, September 30, 2026
Next Filing
Week of Feb 8 and 12 (est)

AMGN.TO Headlines

11/17/2026 - Zacks Investment Research
11/15/2026 - Simply Wall St